Breast

This session provides a global overview of breast radiotherapy indications, approaches and techniques, informed by the latest clinical trials and relevant research. By the completion of the session, participants should be able to identify which patients are suitable for omission of radiation therapy for early stage breast cancer, what kinds of genomic tests have been explored for risk stratification, and what techniques and dose/fractionation schemes demonstrate appropriate efficacy and toxicity profiles for definitive early-stage and locally-advanced breast cancer.

Target Audience

The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, radiation therapists, radiation dosimetrists, nurses and all other health professionals involved in the field of radiation oncology.

Learning Objectives

Upon completion of this activity, participants should be able to do the following:

  • Appropriately identify patients suitable for omission of adjuvant radiation therapy in early-stage breast cancer.
  • Utilize hypofractionation techniques, when applicable, in early-stage and post-mastectomy settings.
  • Understand the relative value and limitations of tumor biology and genomic signatures in risk stratification for breast radiotherapy.
Course summary
Available credit: 
  • 1.75 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.75 Certificate of Attendance
    This activity was designated for 1.75 AMA PRA Category 1 Credit™.
Course opens: 
04/21/2025
Course expires: 
04/20/2027
Cost:
$0.00
Rating: 
0

Faculty Disclosures

Planning Committee Disclosures
 

The person(s) above served as the developer(s) of this activity. Additionally, ASTRO Education Committee had control over the content of this activity.

All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.75 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.75 Certificate of Attendance
    This activity was designated for 1.75 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.